Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Andrology: Testosterone and cardiovascular risk--deciphering the statistics.
Morgentaler A, Kacker R. Morgentaler A, et al. Nat Rev Urol. 2014 Mar;11(3):131-2. doi: 10.1038/nrurol.2014.24. Epub 2014 Feb 18. Nat Rev Urol. 2014. PMID: 24535586 No abstract available.
Is low serum free testosterone a marker for high grade prostate cancer?
Hoffman MA, DeWolf WC, Morgentaler A. Hoffman MA, et al. Among authors: morgentaler a. J Urol. 2000 Mar;163(3):824-7. J Urol. 2000. PMID: 10687985
The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL, Estrada C, Levine L, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Sep;170(3):795-8. doi: 10.1097/01.ju.0000082960.84075.54. J Urol. 2003. PMID: 12913700
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e. J Urol. 2003. PMID: 14634413
Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2004 Feb;16(1):95-7. doi: 10.1038/sj.ijir.3901154. Int J Impot Res. 2004. PMID: 14963480
Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Among authors: morgentaler a. Int J Impot Res. 2006 Mar-Apr;18(2):201-5. doi: 10.1038/sj.ijir.3901394. Int J Impot Res. 2006. PMID: 16177827
Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
Lazarou S, Morgentaler A. Lazarou S, et al. Among authors: morgentaler a. Curr Urol Rep. 2005 Nov;6(6):476-81. doi: 10.1007/s11934-005-0044-z. Curr Urol Rep. 2005. PMID: 16238923 Review.
Testosterone replacement therapy and prostate risks: where's the beef?
Morgentaler A. Morgentaler A. Can J Urol. 2006 Feb;13 Suppl 1:40-3. Can J Urol. 2006. PMID: 16526980 Review.
Testosterone and prostate cancer: an historical perspective on a modern myth.
Morgentaler A. Morgentaler A. Eur Urol. 2006 Nov;50(5):935-9. doi: 10.1016/j.eururo.2006.06.034. Epub 2006 Jul 27. Eur Urol. 2006. PMID: 16875775 Review.
Testosterone therapy for men at risk for or with history of prostate cancer.
Morgentaler A. Morgentaler A. Curr Treat Options Oncol. 2006 Sep;7(5):363-9. doi: 10.1007/s11864-006-0004-y. Curr Treat Options Oncol. 2006. PMID: 16904053 Review.
185 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback